In mammals, the SWI/SNF complex is involved in chromatin remodelling in a wide range of cellular events for which regulatory factors require access to DNA. In the present study, we analyzed in early postimplantation mouse embryos the expression pattern of BRM (SNF2a ) and BRG1 (SNF2b ), which are both ATPase subunits of this complex. Contrarily to the previous studies conducted in adult mice, showing the ubiquitous and overlapping expressions of BRM and BRG1, we show that BRM expression is restricted to mesodermal tissues involved in early vasculogenesis and heart morphogenesis. q
Results and discussion
The SWI/SNF, a multiprotein ATP-dependent complex, plays a major role in chromatin structure¯uidity which in eukaryotes regulates gene expression. Whole-genome expression analysis in yeast has shown that SWI/SNF acts both as a transcriptional activator and repressor (review by Sudarsanam and Winston, 2000) . In humans, the complex containing either ATPase subunit, BRG1 or BRM, is required for transcriptional regulation (Fryer and Archer, 1998; de La Serna et al., 2000; Bochar et al., 2000) . Gene inactivation experiments have shown that BRG1 is essential to cell viability (Sumi-Ichinose et al., 1997) while, in BRM mutants, cell proliferation is altered (Reyes et al., 1998) . Our previous study indicates that BRG1 and BRM have substantially different roles in chromatin remodelling throughout the preimplantation stages (Legouy et al., 1998) . To gain new insight into speci®c functions of the BRM gene after implantation, we analyzed its expression by whole-mount and cryosection immunochemistry from the advanced egg-cylinder stage to the early organogenesis stage.
The BRM protein is ®rst detected in the allantois at the neural plate stage (Fig. 1B) . At the headfold stage, the protein is still expressed in the allantois but also in the amnion (Fig. 1D ) and in the cells of the cardiogenic area (Fig. 1C) , as con®rmed on a transverse section (Fig.  1E ).Meanwhile BRG1 protein is detected in every cells (Fig. 1F,G) . At the 8 somite stage, a sagittal section shows BRM expression in the heart (Fig. 2B, bracket) . At this stage, the primitive heart tube develops and the BRM protein is present from the out¯ow track to the common atrial chamber. The cardiac feature of this region is con®rmed by the immunostaining of GATA-4 (Fig. 2D) , a transcription factor involved in heart morphogenesis (Heikinheimo et al., 1994; Molkentin et al., 1997; Kuo et al., 1997) and expressed in the allantois simultaneously with BRM ( Fig. 2C,E) . In 10 somite embryos, a strong signal is observed in the vitelline artery connecting the embryo to the yolk sac (Fig. 3A) . The inner layer of the yolk sac and the amnion also express BRM (Fig. 3A ,B,D). Sections 3B and 3C (Fig. 3B ,C) con®rm overlapping expression domains in the heart, between BRM and GATA-4. BRM expression then is found in the lateral mesoderm lining the intraembryonic coelomic cavity, the future right and left pericardio-peritoneal canals (Fig. 3D) . The presence of BRM in the allantois and in the inner layer of the yolk sac, where early vasculogenesis and extra-embryonic hematopoiesis initiate, raises the question of the role of BRM in these developmental processes.
To address this issue, we have investigated the expression of BRM with that of the platelet endothelial cell adhesion (A) . The boxed areas in (A) indicate regions that are magni®ed in panels (B±E). BRM protein is located in the heart (B) and in the allantois (C) as for GATA-4 in adjacent sections (D,E). al, allantois; fg, foregut; hg, hindgut; ht, heart; np, neural plate; so, somites. molecule (PECAM-1), a protein speci®c to the emerging vascular network in embryonic and extra-embryonic tissues (Albelda et al., 1991; Baldwin et al., 1994) . At the 15 somite stage, it appears that BRM and PECAM-1 expressions overlap only in the vascular endothelium lining the vitelline artery (Fig. 4F,G) and in the umbilical veins (data not shown). BRM is not expressed in the dorsal aorta (Fig.  4F) , a major PECAM-1 expressing region (Fig. 4G) . In the heart, PECAM-1 expression is restricted to the endocard (Fig. 4B ) whereas BRM and GATA-4 expression is extended to the myocardiac cells (Fig. 4C,D, respectively) . In the yolk sac, BRM expression is restricted to the endothelial cells lining the blood islands but is not expressed in the primitive red blood cells (Fig. 4I) , although vascular endothelium and primitive red blood cells arise from a common mesodermal precursor. The endothelial feature of these BRM expressing cells is con®rmed by the PECAM-1 staining (Fig. 4J) .
In this paper we show that, contrarily to the ubiquitous and overlapping expression of BRM and BRG1 in adult tissues (Chiba et al., 1994; Reyes et al., 1998) , BRM expression is restricted to a few derivatives of mesodermal origin from gastrulation to early organogenesis. Indeed, BRM is expressed in the allantois, the vitelline arteries, the yolk sac and the cardiogenic plate, the ®rst tissues determined to ensure early vascular functions in mouse postimplantation development. This pattern allows us to address the question of the involvement of the BRM gene in early vasculogenesis, an essential process to the establishment and maintenance of linkage between the embryo and the uterus.
Material and methods
Embryonic stages were dissected in M2 media and ®xed for 3 h in paraformaldehyde 4% in PBS at 48C. For cryosection, embryos were immersed overnight at 48C in 18% sucrose/PBS solution, and embedded in 7.5% gelatin/18% sucrose, then frozen over dry ice. Cryotome serial transverse sections (10 mm) were collected and mounted onto SuperFrost slides. For immunostaining, slides and whole-mount samples were treated as previously described for blastocysts (Legouy et al., 1998) . At each stage, several embryos from different litters were analyzed. A,B,D) , and the coelomic cavities (cc) (D). BRM and GATA-4 expressions are both detected in the heart (serial sections B and C). fg, foregut; hg, hindgut; ht, heart; ne, neuroectoderm.
BRG1 and BRM antibodies were described previously (Legouy et al., 1998) , the PECAM-1 and GATA-4 antibodies were purchased respectively from Pharmingen and Santa Cruz Biotechnology. Observations were performed using a Zeiss confocal laser scanning microscope (LSM-310). Fig. 4 . BRM expression at the 15 somite stage. PI staining of a transverse section is shown in (A). Antibody staining in the heart region are magni®ed in serial sections from (B) to (E). PECAM-1 expression is restricted to the endocard (e) (B), whereas BRM and GATA-4 are detected in the myocard (m) and the endocard (C,D). The caudal region is magni®ed in serial sections from (F) to (H). BRM expression is restricted to the vitelline artery (va) (F), PECAM-1 expression is also detected in the dorsal aorta (da) (G). Immunostaining of serial sections of the yolk sac is shown from (I) to (K). BRM and PECAM-1 are detected in endothelial cells lining (edt) the yolk sac (I,J). Ubiquitous expression of BRG1 is shown in (E,H,K). bl, blood cells; end, endoderm; fg, foregut; ht, heart; hg, hindgut; nt, neural tube.
